| dc.contributor.author | Márquez-Expósito, Laura | |
| dc.contributor.author | Tejedor-Santamaría, Lucía | |
| dc.contributor.author | Santos-Sánchez, Laura | |
| dc.contributor.author | Valentijn, Floris A. | |
| dc.contributor.author | Cantero-Navarro, Elena | |
| dc.contributor.author | Rayego-Mateos, Sandra | |
| dc.contributor.author | Rodrigues-Diez, Raúl R. | |
| dc.contributor.author | Tejera-Muñoz, Antonio | |
| dc.contributor.author | Marchant, Vanessa | |
| dc.contributor.author | Sanz, Ana B. | |
| dc.contributor.author | Ortiz, Alberto | |
| dc.contributor.author | Goldschmeding, Roel | |
| dc.contributor.author | Ruiz-Ortega, Marta | |
| dc.date.accessioned | 2025-01-14T15:54:05Z | |
| dc.date.available | 2025-01-14T15:54:05Z | |
| dc.date.issued | 2021 | |
| dc.identifier.citation | Marquez-Exposito, L., Tejedor-Santamaria, L., Santos-Sanchez, L., Valentijn, F. A., Cantero-Navarro, E., Rayego-Mateos, S., ... & Ruiz-Ortega, M. (2021). Acute kidney injury is aggravated in aged mice by the exacerbation of proinflammatory processes. Frontiers in pharmacology, 12, 662020. https://doi.org/10.3389/fphar.2021.662020 | es |
| dc.identifier.issn | 1663-9812 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12020/1473 | |
| dc.description.abstract | Acute kidney injury (AKI) is more frequent in elderly patients. Mechanisms contributing
to AKI (tubular cell death, inflammatory cell infiltration, impaired mitochondrial function,
and prolonged cell-cycle arrest) have been linked to cellular senescence, a process
implicated in regeneration failure and progression to fibrosis. However, the molecular
and pathological basis of the age-related increase in AKI incidence is not completely
understood. To explore these mechanisms, experimental AKI was induced by folic
acid (FA) administration in young (3-months-old) and old (1-year-old) mice, and
kidneys were evaluated in the early phase of AKI, at 48 h. Tubular damage score,
KIM-1 expression, the recruitment of infiltrating immune cells (mainly neutrophils and
macrophages) and proinflammatory gene expression were higher in AKI kidneys of old
than of young mice. Tubular cell death in FA-AKI involves several pathways, such as
regulated necrosis and apoptosis. Ferroptosis and necroptosis cell-death pathways
were upregulated in old AKI kidneys. In contrast, caspase-3 activation was only found
in young but not in old mice. Moreover, the antiapoptotic factor BCL-xL was
significantly overexpressed in old, injured kidneys, suggesting an age-related
apoptosis suppression. AKI kidneys displayed evidence of cellular senescence,
such as increased levels of cyclin dependent kinase inhibitors p16ink4a and
p21cip1, and of the DNA damage response marker γH2AX. Furthermore, p21cip1
mRNA expression and nuclear staining for p21cip1 and γH2AX were higher in old than
in young FA-AKI mice, as well as the expression of senescence-associated secretory
phenotype (SASP) components (Il-6, Tgfb1, Ctgf, and Serpine1). Interestingly, some
infiltrating immune cells were p21 or γH2AX positive, suggesting that molecular
senescence in the immune cells (“immunosenescence”) are involved in the
increased severity of AKI in old mice. In contrast, expression of renal protective
factors was dramatically downregulated in old AKI mice, including the antiaging factor
Klotho and the mitochondrial biogenesis driver PGC-1α. In conclusion, aging resulted
in more severe AKI after the exposure to toxic compounds. This increased toxicity may
be related to magnification of proinflammatory-related pathways in older mice, including a switch to a proinflammatory cell death (necroptosis) instead of apoptosis,
and overactivation of cellular senescence of resident renal cells and infiltrating
inflammatory cells. | es |
| dc.language.iso | en | es |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.title | Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes | es |
| dc.type | article | es |
| dc.identifier.doi | https://doi.org/10.3389/fphar.2021.662020 | |
| dc.journal.title | Frontiers in Pharmacology | es |
| dc.page.initial | 1 | es |
| dc.page.final | 22 | es |
| dc.rights.accessRights | openAccess | es |
| dc.subject.area | Biología Celular y Molecular | es |
| dc.subject.keyword | Aging | es |
| dc.subject.keyword | Necroptosis | es |
| dc.subject.keyword | Apoptosis | es |
| dc.subject.keyword | Cellular Senescence | es |
| dc.subject.keyword | Inflammation | es |
| dc.subject.keyword | Immunosenescence | es |
| dc.subject.keyword | Klotho | es |
| dc.subject.keyword | Acute Kidney Injury | es |
| dc.subject.unesco | 3209 Farmacología | es |
| dc.volume.number | 12 | es |